France Sleep Apnea Devices Market Overview, 2028

In France, Changing lifestyle, a growing geriatric population, and the rising prevalence of chronic disorders is contributing to the growing incidence of OSA. Obstructive Sleep Apnea (OSA) is a sleep disorder with irregular breathing reducing oxygen supply to the brain. The growing prevalence of apnea in the geriatric population remains under diagnosis of OSA due to a lack of awareness amongst individuals and poor presentation of OSA. The increasing life expectancy amongst the global geriatric population is expected to contribute to the growing prevalence of sleep disorders. According to the French National Institute for Statistics and Economic Studies (INSEE), an estimated 7.5% of adults in France have sleep apnea. This means that over 3.2 million people in France are affected by this sleep disorder. Sleep apnea is more common in men than women, and the risk increases with age. Symptoms of sleep apnea can include snoring, gasping for air during sleep, waking up with a dry mouth or headache, and daytime fatigue. If you experience any of these symptoms, it is important to see a doctor to get a diagnosis and treatment. Treatment for sleep apnea typically includes lifestyle changes, such as losing weight if you are overweight, quitting smoking, and avoiding alcohol before bed. In some cases, a CPAP machine may be prescribed to help keep the airway open during sleep. There is growing awareness of sleep apnea in France, thanks to public health campaigns and media coverage. This is leading more people to seek diagnosis and treatment for the condition. According to the research report "France Sleep Apnea Therapeutic Devices Market Overview, 2028," published by Bonafide Research, the France Sleep Apnea Therapeutic Devices market is expected to reach market size of more than USD 350 Million by 2028. The trend towards home sleep testing services is growing, allowing individuals to undergo sleep apnea diagnostic testing in the comfort of their homes. This trend aligns with the broader shift towards decentralized healthcare and patient-centered approaches. AI is increasingly being utilized not only for diagnostics but also for optimizing treatment plans. Adaptive therapy algorithms can analyse patient responses to treatment and dynamically adjust device settings to optimize efficacy, contributing to better outcomes. There is a growing recognition of pediatric sleep apnea, leading to increased attention on developing therapeutic devices specifically designed for children. The market is witnessing innovations in devices tailored to meet the unique needs of pediatric patients. The exploration of hybrid and multimodal therapies for sleep apnea is emerging. This includes combining different therapeutic approaches, such as oral appliances and positional therapy, to offer more tailored solutions for patients with varying needs and preferences. The establishment of virtual sleep clinics and remote consultations is becoming more common. These virtual healthcare services provide patients with easier access to sleep specialists and facilitate the ongoing management of sleep apnea. The adoption of 3D printing technology in the manufacturing of sleep apnea devices is a growing trend. This allows for the creation of customized and precisely tailored devices, improving the fit and comfort for individual patients. Beyond the initial purchase, there are ongoing costs associated with the maintenance of sleep apnea devices. This includes the regular replacement of components like masks and filters, as well as the cost of cleaning and disinfecting the equipment. These maintenance costs can accumulate over time.

Based on product the market is categorized into Positive Airway Pressure (PAP) Device, Adaptive Servo-Ventilation (ASV), Airway Clearance Systems, Oxygen Devices, Oral Appliances and Others (Nasal dilators, Positional therapy, Surgical procedures, Electrical stimulation devices). ASV Systems use adaptive technology to monitor and adjust airflow based on the patient's breathing patterns. This adaptability can enhance patient comfort and improve therapy effectiveness, making ASV Systems an attractive option for certain individuals. ASV Systems are specifically designed to reduce the frequency of central sleep apnea events by adjusting ventilation support as needed. This targeted approach to addressing central sleep apnea contributes to the appeal of ASV Systems for patients and healthcare providers. ASV Systems provide comprehensive therapy by addressing not only obstructive events but also central events. This dual-action capability allows for a more holistic approach to treating sleep-disordered breathing, potentially improving overall patient outcomes. ASV Systems offer individualized pressure support based on real-time monitoring of the patient's respiratory patterns. This dynamic adjustment can optimize therapy delivery, particularly for patients with varying breathing needs throughout the night. ASV Systems are versatile and can be used to treat a spectrum of sleep apnea severity, from mild to severe cases. The adaptability of ASV therapy makes it suitable for a broad patient population with different levels of respiratory impairment. Home care settings provide a more convenient and comfortable environment for individuals undergoing sleep apnea therapy. Patients can sleep in their own beds, follow personalized schedules, and experience fewer disruptions to their daily routines compared to hospital stays. The availability of portable and user-friendly sleep apnea therapeutic devices contributes to the success of home care settings. Technological advancements have led to the development of compact and easy-to-use devices, making it feasible for individuals to manage their therapy at home. Home care settings empower patients to take an active role in managing their sleep apnea. Individuals can be more engaged in their treatment plans, leading to improved adherence to therapy and better long-term outcomes. Home care settings offer flexibility in treatment schedules. Patients can adhere to their therapy routines without being constrained by hospital schedules, leading to increased patient satisfaction and adherence rates. Individuals with mild to moderate sleep apnea may find home-based therapy sufficient for managing their condition. Portable devices designed for these cases can effectively address the needs of a significant portion of the patient population. Considered in this report: • Geography: France • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report: • France Sleep Apnea Therapeutic Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • Therapeutic Devices • Diagnostic Devices By End User • Home care Settings & Individuals • Sleep laboratories & Hospitals

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Sleep Apnea Therapeutic Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.